NCT00081276 2013-01-24
3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Carcinoma, Ovarian Epithelial × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all